VIPER: Veterans Integrated Pain Evaluation Research
VIPER
1 other identifier
observational
124
1 country
1
Brief Summary
The purpose of the study is to learn about the causes of different types of pain that can occur in people who have had an amputation. By gathering information through blood tests, photographs, a nerve test, and questionnaires, we hope to de-code how each individual's special characteristics affect the type and amount of pain they experience in their amputated limb.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jan 2012
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2012
CompletedFirst Submitted
Initial submission to the registry
October 17, 2012
CompletedFirst Posted
Study publicly available on registry
October 29, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2017
CompletedAugust 14, 2019
August 1, 2019
1.8 years
October 17, 2012
August 13, 2019
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Proteomics
To determine which proteins represent circulating qualitative and quantitative biomarkers of pain.
1 day
Eligibility Criteria
Male and female active duty military personnel age 18 years and older presenting with the diagnosis of amputation of 1 limb in the previous 18 months. At least 3 months must have passed since the first amputation procedure.
You may qualify if:
- Male and female active duty military personnel age 18 years and older undergoing treatment at WRAMC and future WRNMMC with the diagnosis of post injury amputation of 1 limb, more than 3 but less than 18 months prior to enrollment. In particular, phantom limb pain patients will be included
You may not qualify if:
- Severe Traumatic Brain Injury (Primary major head trauma and diagnosis of traumatic brain injury resulting in documented, permanent or prolonged cognitive deficits that would preclude participation in the study (i.e. decreased intellectual capacity, marked memory deficits, or inability to communicate verbally or in writing)
- Significant cognitive deficits that would preclude participation in the study.
- Substantial hearing loss without alternative means of communication.
- Documented spinal cord injury with permanent or persistent deficits.
- Diagnosis of fibromyalgia or other chronic pain syndrome such as chronic headaches.
- Evidence of ongoing tissue damage pain, infection, bone spur, or poorly fitting prosthesis.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Walter Reed National Military Medical Center
Bethesda, Maryland, 20889, United States
Biospecimen
Blood draw will consist of, two BD™ P100 tubes (2x8.5mL=17mL) where the plasma will be separated by centrifuge then placed in a -80ºC freezer. Two RNA tubes (2 x 2.5mL=5mL) and one DNA tube (8.5mL) will be place first, in a -20ºC freezer for 24-36 hours then moved to a -80ºC freezer. All the blood samples will remain in a -80ºC freezer at the Department of Clinical Investigation(DCI) laboratory until they are sent to Duke University after every 8 subjects.
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
October 17, 2012
First Posted
October 29, 2012
Study Start
January 1, 2012
Primary Completion
October 1, 2013
Study Completion
February 1, 2017
Last Updated
August 14, 2019
Record last verified: 2019-08